Published in TB and Outbreaks Week, August 10th, 2004
A Food and Drug Administration (FDA) official briefed the agency's Blood Products advisory committee about the recommendation. Depending on its effect on the blood supply, the guidance could be finished as early as this fall.
Already, West Nile is racing through this summer's hot spots, sickening and killing people in Arizona, California and Colorado. Sensitive tests have tagged 61 potentially infected donors, whose blood donations were yanked from shelves, Hira...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.